This information was published on 2026-07-19T00:03:18 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2629735 |
| (220) |
23 Feb 2026
|
| (300) |
US, 18 Feb 2026, 99659574
|
| (511) (510) |
Class 5
Gene therapy products, namely, genetically engineered tissues for transplant purposes; pharmaceutical preparations for gene therapy for the treatment of ocular disease, such as Stargardt Disease; pharmaceutical preparations for gene therapy for the treatment of Stargardt Disease |
| (540) | FYSTARZI |
| (550) | Word |
| (730) |
Ocugen, Inc.
|
| (750) |
LAMINAR IP PTY LTD
|
Find out more about publications on the About page.